Medicines Council chairman looks back after two years: "We had experiences we did not prepare for"
After two years, an external body is now to evaluate whether the Danish Medicines Council serves its purpose and its political working conditions. According to co-chairman, the council has made a good start despite challenges on the way.
Objectivity policy, the Spinraza case, political cross pressure and the arm's length principle. 12 week-deadlines, the principle of openness and intense media attention.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Danish Medicines Council postpones diabetes guidelines
For abonnenter
